Dysregulation of the IgE/FcεRI network in HIV-1 infection

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 1, 2001, Pages 22-30

  Marone, Gianni ^a   Florio, Giovanni ^a   Petraroli, Angelica ^a   De Paulis, Amato ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

AIDS; Basophils; CCR3; Chemokine; HIV 1; IL 13; IL 4; Mast cells; Tat

Indexed keywords

CHEMOKINE RECEPTOR CCR3; EOTAXIN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 13; INTERLEUKIN 4; RANTES; SUPERANTIGEN; TRANSACTIVATOR PROTEIN;

BASOPHIL; CYTOKINE RELEASE; DISEASE MARKER; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; INFECTION SENSITIVITY; MAST CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REVIEW;

EID: 0035141802     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.111589     Document Type: Article

References (58)

1. The AIDS epidemic. Considerations for the 21st century
2. Prevalence and etiology of asthma
3. Host factors and the pathogenesis of HIV-induced disease
4. Asthma: Recent advances
5. The role of lymphocytes in allergic disease
6. + T-cells
7. Serum IgE and human immunodeficiency virus (HIV) infection
8. Elevated IgE level in relationship to nutritional status and immune parameters in early human immunodeficiency virus-1 disease
9. Serum total and specific IgE levels in children infected with human immunodeficiency virus
10. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals
11. + T-cell clones in human immunodeficiency virus infection
12. Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection
13. Cutaneous disease and drug reaction in HIV infection
14. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS)
15. Pneumocystis carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies
16. HIV antigen-induced release of histamine from basophils from HIV infected patients. Mechanism and relation to disease progression and immunodeficiency
17. H3 region of IgE
18. The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils
19. Enhanced basophil releasability in subjects infected with human immunodeficiency virus
20. H3 region of IgE
21. Interleukin 4 is localized to and released by human mast cells
22. Activated mast cells produce interleukin 13
23. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, and IL-13, and can induce IgE synthesis in B cells
24. Elevation of IgE in HIV-infected subjects: A marker of poor prognosis
25. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus
26. Elevation of IgE in HIV-infected children and its correlation with the progression of disease
27. IgE serum level: A prognostic marker for AIDS in HIV-infected adults?
28. A Th1-Th2 switch is a critical step in the etiology of HIV infection
29. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS)
30. Resistance to murine acquired immunodeficiency syndrome (MAIDS)
31. H2 predominance in HIV-infected individuals
32. H0 cells
33. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry
34. HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state
35. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients
36. In vivo alteration in type-1 and type-2 cytokine balance: A possible mechanism for elevated total IgE in HIV-infected patients
37. Atopy, anergic status, and cytokine expression in HIV-infected subjects
38. Increased T-helper-type 2 cytokine production in chronic HIV infection is due to interleukin (IL)-13 rather than IL-4
39. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
40. HIV-1-entry cofactor: Functional cDNA cloning of a seven-transmembrane, G-protein-coupled receptor
41. The b-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
42. Identification of the B cell superantigen-binding site of HIV-1 gp120
43. H3 gene products: Natural ligands for HIV gp120
44. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13
45. Frequency and characterization of antigen-specific IL-4- and IL-13-producing basophils and T cells in peripheral blood of healthy and asthmatic subjects
46. Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-γ on fusin/CXCR4
47. + T cell depletion in HIV-1-infected human lymphoid tissue
48. Divergent effects of interleukin-4 and interferon-γ on macrophage-derived chemokine production: An amplification circuit of polarized T helper 2 responses
49. Regulation of HIV-1 gene expression by the transactivator protein Tat
50. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
51. Cellular uptake of the tat protein from human immunodeficiency virus
52. HIV-1 Tat protein mimicry of chemokines
53. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines
54. Impaired mast cell-dependent natural immunity in complement C3-deficient mice
55. Human mast cells and basophils in immune responses to infectious agents
56. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E
57. + cells